An 83-year-old male presented with chronic diarrhea and protein malnutrition associated with Plesiomonas shigelloides overgrowth in the small intestine. This overgrowth was related to achlorhydria and small-bowel diverticula. Tests for heat-labile and heat-stable enterotoxin were negative on the P. shigelloides isolated from both the small bowel aspirate (3 x 108 bacteria per ml) and the patient's stool. The patient responded satisfactorily to tetracycline, to which this unusual isolate was susceptible in vitro. The ability to correctly identify and determine the antimicrobial susceptibility of P. shigelloides in the setting of smallbowel overgrowth will help determine appropriate therapy.
, bacteremia secondary to cellulitis (8) , and meningitis (1) . This report describes a patient with chronic diarrhea and protein malnutrition associated with overgrowth of the small bowel by P. shigelloides. CASE 
REPORT
An 83-year-old white male was admitted to the Omaha Veterans Administration Medical Center in November 1979 because of diarrhea. He had developed intermittently loose stools 3 months before admission. For 2 weeks before admission, he had watery diarrhea, with a stool frequency offive to six times per day. Vomiting had developed 48 h before admission. The patient denied abdominal pain, fever, or chills.
On examination, the patient was weak and pale. He was afebrile with a supine blood pressure of 100/55 and a sitting blood pressure of 90/50. His height and weight were 67 in. (170.18 cm) and 152 lb. (69.1 kg), respectively. He had bilateral cataracts and was edentulous. Cardiopulmonary examination was normal. The abdomen was nontender and without masses. There was moderate pitting ankle edema. Neurological exam showed mildly decreased vibratory and pain sensation in the lower extremities. Laboratory studies showed a hemoglobin level of 8.0 g/dl, hematocrit of 24%, erythrocyte count of 2.39
x 106/mm3, mean corpuscular volume of 101 ,uMm3, and t Present address: Department of Epidemiology, Nebraska Methodist Hospital, Omaha, NE 68114. mean corpuscular hemoglobin of 33.5 pg. The leukocyte count was 1,400/mm,3 with 434 granulocytes and 882 lymphocytes. The platelet count was 144,000/ mm3, and the absolute reticulocyte count was 27,400/ mm3. The total serum protein was 4.09 g/dl, and serum albumin was 2.24 g/dl. The serum folate was 6.2 ng/ml, and the serum vitamin B12 was zero. A fasting serum gastrin level was 718 pg/ml (elevated 3x normal). A radioimmunoassay for serum intrinsic factor antibodies was negative. An indirect immunofluorescent antibody test for serum parietal cell antibodies was positive. The creatinine clearance was 37 cc/min. A bone marrow aspirate demonstrated megaloblastic changes with increased iron stores. The patient was achlorhydric by gastric analysis. An upper gastrointestinal and small-bowel series demonstrated multiple small-intestine diverticula.
P. shigelloides was isolated from the stool culture. A duodenal aspirate grew 3 x 108 P. shigelloides organisms per ml. All stool samples and duodenal aspirates were negative for enteric pathogens and ova and parasites. The patient was given intravenous hydration, parenteral vitamin B12, and a 7-day course of tetracycline, 250 mg four times a day oially. The patient was passing well-formed stools twice a day after completion of antibiotic therapy.
At follow-up 2 months later, the patient was free of diarrhea. Repeat culture of the stool and a duodenal aspirate was negative for P. shigelloides but showed 5 x 10' Escherichia coli organisms per ml resistant to tetracycline and sensitive to trimethoprim-sulfamethoxazole. The patient was given trimethoprim (160 mg)-sulfamethoxazole (800 mg) tablets and instructed to take one daily for 7 consecutive days every month.
Because the previous studies had also suggested pernicious anemia, monthly vitamin B12 shots were continued. The patient did well during 1.5 years offollow-up.
MATERUILS AND METHODS
A stool specimen was examined microscopically for leukocytes and for ova and parasites (direct and Formalin-ether concentration) and tested for occult blood on October 11, 2017 by guest http://jcm.asm.org/ Downloaded from (Hematest; Ames Division, Miles Laboratories, Inc., Elkhart, Ind.). Both fecal material and duodenal aspirates were cultured for bacterial pathogens by plating on MacConkey agar, Hektoen-enteric agar, and xylose-lysine-desoxycholate agar. In addition, fecal specimens were subcultured onto Hektoen-enteric and xylose-lysine-desoxycholate agars after overnight (35°C) incubation in selenite broth; duodenal fluid was quantitatively cultured aerobically and anaerobically (on MacConkey and sheep-blood agar plates).
Suspected enteric bacterial pathogens from differential media were screened for the rapid production of urease (Christensen urea at 35°C for 4 h). Ureasenegative isolates were then identified with the API 20E system (Analytab Products, Plainview, N.Y.). All clinical isolates were submitted to Analytab Products for API 50E tests.
The antimicrobial susceptibility of isolates was determined by the disk diffusion technique of Bauer et al. (2) and by a microdilution method (Sensititre; GIBCO Laboratories, Lawrence, Mass.).
A small-bowel (duodenal) biopsy was obtained during endoscopy and was immediately fixed in buffered (pH 7) Formalin. Tissue was subsequently rehydrated, fixed in osmium tetroxide, and embedded in a lowviscosity epoxy resin for thin sectioning before electron microscopic examination.
To perform toxin assays, fresh isolates of the organism were cultivated in 250-ml Erlenmeyer flasks containing 40 ml of brain heart infusion broth (Difco Laboratories, Detroit, Mich.) for 24 h at 24°C as previously described (16, 21) . All flasks were shaken on a platform shaker at 160 rpm. After incubation, the broth cultures were centrifuged at 12,100 x g for 45 min at 4°C, and the supernatants were sterilized by membrane filtration (0.45 FLm; Millipore Corp., Bedford, Mass.). The sterile culture supernatants were then assayed at once for biotoxicity.
The infant mouse model of Dean et al. (6) was used to assay for heat-stable enterotoxin. Briefly, 2-day-old infant mice were randomly placed in groups of four, injected with a 0.1-ml sample containing 0.02% Niagara Sky Blue, and incubated at room temperature for 3 h. The animals were then sacrificed by decapitation, and the entire intestinal tract was removed and weighed. The ratio of intestinal to remaining body weight was used as a measure of the amount of toxic activity, as described elsewhere (6) . A ratio of 0.083 or greater was considered positive for enterotoxic activity. Both negative (buffer) and positive (E. coli heatstable enterotoxin) controls were performed with each assay.
The Y-1 adrenal cell assay of Donta (7) was used to assay for heat-labile enterotoxin. Mouse adrenal cells were cultured in a plastic microtiter plate to 80% confluency. The cells were maintained in minimal essential medium F15 (GIBCO Laboratories, Grand Island, N.Y.) and supplemented with heat-inactivated 10%o fetal calf serum at 37°C in a humidified atmosphere of 5% CO2 in air. The microtiter wells were challenged with serial twofold dilutions of the cell-free filtrate. Negative and positive controls consisted of buffer (diluent) or cholera enterotoxin, respectively. Changes in monolayer morphology were determined after 24 h of incubation. The highest dilutions showing in excess of 90% cell rounding were considered the endpoint (7). RESULTS Stool examinations were negative for both fecal leukocytes and occult blood. All tests for enteric pathogens (Salmonella and Shigella) and ova and parasites were negative. Neither Giardia lamblia trophozoites nor cysts were detected in the duodenal aspirate.
P. shigelloides was isolated from a fecal specimen (3+ primary growth) and subsequently from a duodenal aspirate. Colonies appeared colorless on MacConkey agar, colorless to light blue on Hektoen-enteric agar, and red on xylose-lysine-desoxycholate agar and were negative when screened for urease production. Additional testing in the API 20E system resulted in the profile number 7-144-204 and excellent identification (1/1) for P. shigelloides. Additional tests performed in biotyping with the API 50E system showed that this strain, in contrast to two other isolates of P. shigelloides recovered from clinical specimens in this locale during the same approximate period of time, did not utilize galactose (Table 1 ). Other biochemical reactions were identical.
The appearance of Kligler iron agar slants after overnight incubation was similar to that produced by species in the genus Shigella, i.e., an alkaline slant over an acidified butt without gas production. Several attempts were made to presumptively identify these isolates with antiShigella serum (types A through D; Lederle Laboratories, Pearl River, N.Y.) against both heated and unheated saline suspensions of organisms. No agglutination was detected by these means. The results of disk diffusion antimicrobial susceptibility testing and quantitative (microdilution) determination of the minimum inhibitory concentrations were in close agreement (Table 2) .
Plate counts from serial dilutions of duodenal fluid, cultured both aerobically and anaerobically, showed P. shigelloides present at approximately 3 x 108 colony-forming units per ml. Only a few colonies of E. coli were on plates from lower dilutions.
The small-bowel tissue obtained by peroral biopsy was normal by routine histological examination. Tissue examined ultramicroscopically showed minimal and nonspecific changes in the microvillus surface.
All stool and duodenal isolates of P. shigelloides were tested for ability to produce enterotoxic activity. Cell-free culture supernatants prepared from these isolates were consistently negative in the infant mouse and cultured adrenal cell assays for enterotoxic activities. Because assays reported here for heat-labile and heat-stable enterotoxin were negative, the precise role of P. shigelloides in the pathophysiology of the diarrhea in our patient remains uncertain. However, we propose that the diarrhea in our patient resulted from the pathophysiological events that can accompany overgrowth of any one of a variety of bacteria in the small bowel.
DISCUSSION
Two factors appeared to be present in our patient to allow overgrowth of P. shigelloides in the small intestine. The first factor was the patient's achlorhydria. The achlorhydric stomach serves as a reservoir of bacteria for contamination of the small intestine. The numbers of bacteria have been shown to increase in the small intestine of patients with spontaneous achlorhydria (11) . However, King and Toskes (15) have emphasized the importance of normal anatomy or antroduodenal innervation or both in prevention of small-bowel bacteria overgrowth. Consequently, the stagnation of intestinal contents associated with diverticulosis of the small intestine in our patient may have been the second and the major factor for the abnormal proliferation of P. shigelloides.
There appear to be several mechanisms by which bacteria cause disease during overgrowth in the small intestine. These mechanisms relate to disturbances of the intraluminal environment within the small intestine as well as direct mucosal injury. These changes result in malabsorption that can be manifested as diarrhea (15) . Although the macrocytic anemia in our patients can be explained by the presence of pernicious anemia, P. shigelloides could well have been binding to free vitamin B12. Giannella et al. (9) have demonstrated the avid binding of facultative gram-negative bacteria to free vitamin B12. Hypoproteinemia that was present in our patient can occur in the overgrowth syndrome and has several etiologies. These include increased intraluminal deamination of protein precursors by the small intestinal bacteria and decreased participation of mucosal enzymes in digestion of protein related to mucosal injury associated with overgrowth (15) .
As in our patient, management of small intestine bacterial overgrowth usually is centered around medical and nutritional support modalities. Antibiotic therapy should be based upon the results of the in vitro culture of the intestinal secretions. Obtaining such a specimen is desirable for diagnosing bacterial overgrowth of the small intestine and identifying the antimicrobial susceptibility pattern of the organism (10). Although our isolate was sensitive to tetracycline, we have recently encountered a second strain of P. shigelloides resistant to this antibiotic (minimal inhibitory concentration, 32 jig/ml) in a 2-year-old girl with diarrhea (unpublished observation). This finding emphasizes the importance of in vitro antibiotic susceptibility testing before therapy. Many patients will remain asymptomatic for months after a brief course of antimicrobial therapy. Others will require intermittent antibiotic therapy for control of their disease (15) .
This report documents for the first time the association of P. shigelloides with the smallbowel overgrowth syndrome. The ability to identify and determine the antimicrobial susceptibility pattern of this unusual isolate in this setting will help determine appropriate therapy. Further study of the role of P. shigelloides in gastrointestinal disease appears warranted.
